Association of T-Cell Receptor Repertoire Use With Response to Combined Trastuzumab-Lapatinib Treatment of HER2-Positive Breast Cancer Secondary Analysis of the NeoALTTO Randomized Clinical Trial

Ryan L Powles; David Redmond; Christos Sotiriou; Sherene Loi; Debora Fumagalli; Paolo Nuciforo; Nadia Harbeck; Evandro de Azambuja; Severine Sarp; Serena Di Cosimo; Jens Huober; Jose Baselga; Martine Piccart-Gebhart; Olivier Elemento; Lajos Pusztai; Christos Hatzis

Journal article

Association of T-Cell Receptor Repertoire Use With Response to Combined Trastuzumab-Lapatinib Treatment of HER2-Positive Breast Cancer Secondary Analysis of the NeoALTTO Randomized Clinical Trial

Ryan L Powles, David Redmond, Christos Sotiriou, Sherene Loi, Debora Fumagalli, Paolo Nuciforo, Nadia Harbeck, Evandro de Azambuja, Severine Sarp, Serena Di Cosimo, Jens Huober, Jose Baselga, Martine Piccart-Gebhart, Olivier Elemento, Lajos Pusztai, Christos Hatzis

JAMA Oncology | AMER MEDICAL ASSOC | Published : 2018

DOI: 10.1001/jamaoncol.2018.1564

University of Melbourne Researchers

Sherene Loi Author The Sir Peter MacCallum Department of Oncology

Grants

Awarded by Yale Cancer Center Core Grant

Awarded by NATIONAL CANCER INSTITUTE

Funding Acknowledgements

This project was supported by Investigator Awards from the Breast Cancer Research Foundation and by a Yale Cancer Center Core Grant (NCI P30 CA16359-34) to Drs Hatzis and Pusztai and by a Susan G. Komen Foundation grant to Dr Pusztai.